Pimozide-d4-1 is a deuterium-labeled version of Pimozide, a dopamine receptor antagonist. It exhibits Ki values of 1.4 nM for D2, 2.5 nM for D3, and 588 nM for D1 receptors, along with affinity at the α1-adrenoceptor (Ki of 39 nM). Additionally, Pimozide inhibits STAT3 and STAT5. Deuterium labeling allows for its use as a tracer and internal standard in quantitative analyses, impacting pharmacokinetic and metabolic profiles of drugs.
- Deuterium-labeled compound
- Functions as a dopamine receptor antagonist
- Exhibits affinity at α1-adrenoceptor
- Inhibits STAT3 and STAT5
- Useful as a tracer in drug development
- Serves as an internal standard for quantitative analysis (NMR, GC-MS, LC-MS)
- Impacts pharmacokinetic and metabolic profiles of drugs